, the Fondation pour la Recherche Medicale (MV), l'association CIEL, l'association L'Un pour l'Autre et la fédération Ensangble (MV), a grant FEDER, MV), the Association pour la Recherche contre le Cancer (MV)

. Objectif-competitivite, SOE2/P1/E341 from Sudoe/Interreg IV B (EU to MV) and fellowships from La Ligue Contre le Cancer (NL-R) and from the ARC and the Higher Education Commission

, References

S. Alvarez-fernandez, M. Ortiz-ruiz, T. Parrott, S. Zaknoen, E. Ocio et al., Potent Antimyeloma Activity of a Novel ERK5/CDK Inhibitor, Clinical Cancer Research, vol.19, issue.10, pp.2677-87, 2013.
DOI : 10.1158/1078-0432.CCR-12-2118

L. Arias-gonzalez, I. Moreno-gimeno, A. Del-campo, L. Serrano-oviedo, M. Valero et al., ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma, Neoplasia, vol.15, issue.6, pp.649-59, 2013.
DOI : 10.1593/neo.121896

V. Audrito, T. Vaisitti, D. Rossi, D. Gottardi, D. 'arena et al., Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network, Cancer Research, vol.71, issue.13, pp.4473-83, 2011.
DOI : 10.1158/0008-5472.CAN-10-4452

N. Bellance, P. Lestienne, and R. Rossignol, Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis, Front Biosci, vol.14, pp.4015-4049, 2009.

C. Bradbury, F. Khanim, R. Hayden, C. Bunce, D. White et al., Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors, Leukemia, vol.60, issue.10, pp.1751-1760, 2005.
DOI : 10.1007/s00018-003-3090-z

M. Buschbeck, S. Hofbauer, L. Croce, G. Keri, and A. Ullrich, Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival, EMBO reports, vol.62, issue.1, pp.63-72, 2005.
DOI : 10.1067/msy.2002.125389

X. Carvajal-vergara, S. Tabera, J. Montero, A. Esparis-ogando, R. Lopez-perez et al., Multifunctional role of Erk5 in multiple myeloma, Blood, vol.105, issue.11, pp.4492-4501, 2005.
DOI : 10.1182/blood-2004-08-2985

S. Charni, J. Aguilo, J. Garaude, G. De-bettignies, C. Jacquet et al., ERK5 Knockdown Generates Mouse Leukemia Cells with Low MHC Class I Levels That Activate NK Cells and Block Tumorigenesis, The Journal of Immunology, vol.182, issue.6, pp.3398-405, 2009.
DOI : 10.4049/jimmunol.0803006

URL : https://hal.archives-ouvertes.fr/hal-00368654

S. Charni, G. De-bettignies, M. Rathore, J. Aguilo, P. Van-den-elsen et al., Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 Pathway, The Journal of Immunology, vol.185, issue.6, pp.3498-503, 2010.
DOI : 10.4049/jimmunol.1001250

S. Chung, H. Yao, S. Caito, J. Hwang, G. Arunachalam et al., Regulation of SIRT1 in cellular functions: Role of polyphenols, Archives of Biochemistry and Biophysics, vol.501, issue.1, pp.79-90, 2010.
DOI : 10.1016/j.abb.2010.05.003

C. Clape, V. Fritz, C. Henriquet, F. Apparailly, P. Fernandez et al., miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice, PLoS ONE, vol.4, issue.10, p.7542, 2009.
DOI : 10.1371/journal.pone.0007542.g004

URL : https://hal.archives-ouvertes.fr/inserm-00431462

D. Drechsel and M. Patel, Removal in Brain Mitochondria via the Thioredoxin/Peroxiredoxin System, Journal of Biological Chemistry, vol.368, issue.36, pp.27850-27858, 2010.
DOI : 10.1128/MCB.20.19.7311-7318.2000

B. Gao, Q. Kong, K. Kemp, Y. Zhao, and D. Fang, Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance, Proceedings of the National Academy of Sciences, vol.29, issue.19, pp.899-904, 2012.
DOI : 10.1128/MCB.00407-09

J. Garaude, S. Cherni, S. Kaminski, E. Delepine, C. Chable-bessia et al., ERK5 Activates NF-??B in Leukemic T Cells and Is Essential for Their Growth In Vivo, The Journal of Immunology, vol.177, issue.11, pp.7607-7624, 2006.
DOI : 10.4049/jimmunol.177.11.7607

URL : https://hal.archives-ouvertes.fr/hal-00119762

J. Garaude, R. Farras, G. Bossis, S. Charni, M. Piechaczyk et al., SUMOylation Regulates the Transcriptional Activity of JunB in T Lymphocytes, The Journal of Immunology, vol.180, issue.9, pp.5983-90, 2008.
DOI : 10.4049/jimmunol.180.9.5983

J. Garaude, S. Kaminski, S. Cherni, R. Hipskind, and M. Villalba, The Role of ERK5 in T-Cell Signalling, Scandinavian Journal of Immunology, vol.163, issue.6, pp.515-535, 2005.
DOI : 10.1128/MCB.20.22.8382-8389.2000

K. Hasegawa, S. Wakino, K. Yoshioka, S. Tatematsu, Y. Hara et al., Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression, Biochemical and Biophysical Research Communications, vol.372, issue.1, pp.51-57, 2008.
DOI : 10.1016/j.bbrc.2008.04.176

T. Hitosugi, S. Kang, V. Heiden, M. Chung, T. Elf et al., Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth, Science Signaling, vol.2, issue.97, p.73, 2009.
DOI : 10.1126/scisignal.2000431

P. Jezek, L. Plecita-hlavata, K. Smolkova, and R. Rossignol, Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development, The International Journal of Biochemistry & Cell Biology, vol.42, issue.5, pp.604-626, 2010.
DOI : 10.1016/j.biocel.2009.11.008

J. Kaspar, S. Niture, and A. Jaiswal, Nrf2:INrf2 (Keap1) signaling in oxidative stress, Free Radical Biology and Medicine, vol.47, issue.9, pp.1304-1313, 2009.
DOI : 10.1016/j.freeradbiomed.2009.07.035

T. Kensler and N. Wakabayashi, Nrf2: friend or foe for chemoprevention?, Carcinogenesis, vol.100, issue.1, pp.90-99, 2010.
DOI : 10.1016/S0092-8674(00)81683-9

M. Kim, S. Kim, J. Lim, C. Lee, H. Choi et al., Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation, Journal of Biological Chemistry, vol.82, issue.48, pp.40722-40753, 2012.
DOI : 10.1186/1471-213X-3-11

T. Kozako, A. Aikawa, T. Shoji, T. Fujimoto, M. Yoshimitsu et al., High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells, International Journal of Cancer, vol.3, issue.9, pp.2044-55, 2012.
DOI : 10.1016/j.chom.2008.02.002

L. Li, M. Li, C. Sun, L. Francisco, S. Chakraborty et al., Altered Hematopoietic Cell Gene Expression Precedes Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia and Identifies Patients at Risk, Cancer Cell, vol.20, issue.5, pp.591-605, 2011.
DOI : 10.1016/j.ccr.2011.09.011

L. Li, L. Wang, Z. Wang, Y. Ho, T. Mcdonald et al., Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib, Cancer Cell, vol.21, issue.2, pp.266-81, 2012.
DOI : 10.1016/j.ccr.2011.12.020

J. Lim, Y. Lee, Y. Chun, J. Chen, J. Kim et al., Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1??, Molecular Cell, vol.38, issue.6, pp.864-78, 2010.
DOI : 10.1016/j.molcel.2010.05.023

E. Mardis, L. Ding, D. Dooling, D. Larson, M. Mclellan et al., Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome, New England Journal of Medicine, vol.361, issue.11, pp.1058-66, 2009.
DOI : 10.1056/NEJMoa0903840

P. Nigro, J. Abe, and B. Berk, Flow Shear Stress and Atherosclerosis: A Matter of Site Specificity, Antioxidants & Redox Signaling, vol.15, issue.5, pp.1405-1419, 2011.
DOI : 10.1089/ars.2010.3679

C. Oliveras-ferraros, S. Cufi, A. Vazquez-martin, O. Menendez, J. Bosch-barrera et al., Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformation, Cell Cycle, vol.405, issue.5, 2012.
DOI : 10.1016/j.bbrc.2011.01.075

URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.11.5.19252?needAccess=true

J. Prensner and A. Chinnaiyan, Metabolism unhinged: IDH mutations in cancer, Nature Medicine, vol.28, issue.3, pp.291-294, 2011.
DOI : 10.1200/JCO.2010.28.3762

B. Ramachandran, G. Yu, and T. Gulick, Nuclear Respiratory Factor 1 Controls Myocyte Enhancer Factor 2A Transcription to Provide a Mechanism for Coordinate Expression of Respiratory Chain Subunits, Journal of Biological Chemistry, vol.112, issue.18, pp.11935-11981, 2008.
DOI : 10.1016/j.ydbio.2003.12.004

B. Ramachandran, G. Yu, S. Li, B. Zhu, and T. Gulick, Myocyte Enhancer Factor 2A Is Transcriptionally Autoregulated, Journal of Biological Chemistry, vol.20, issue.16, pp.10318-10347, 2008.
DOI : 10.1126/science.275.5296.90

URL : http://www.jbc.org/content/283/16/10318.full.pdf

M. Rathore, A. Saumet, J. Rossi, C. De-bettignies, D. Tempe et al., The NF-??B member p65 controls glutamine metabolism through miR-23a, The International Journal of Biochemistry & Cell Biology, vol.44, issue.9, pp.1448-56, 2012.
DOI : 10.1016/j.biocel.2012.05.011

E. Razumovskaya, J. Sun, and L. Ronnstrand, Inhibition of MEK5 by BIX02188 induces apoptosis in cells expressing the oncogenic mutant FLT3-ITD, Biochemical and Biophysical Research Communications, vol.412, issue.2, pp.307-319, 2011.
DOI : 10.1016/j.bbrc.2011.07.089

L. Reitzer, B. Wice, and D. Kennell, Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells, J Biol Chem, vol.254, pp.2669-76, 1979.

C. Rene, E. Lopez, M. Claustres, M. Taulan, and M. Romey-chatelain, NF-E2-related factor 2, a key inducer of antioxidant defenses, negatively regulates the CFTR transcription, Cellular and Molecular Life Sciences, vol.3, issue.2???3, pp.2297-309, 2010.
DOI : 10.1152/ajpcell.00457.2002

R. Rossignol, R. Gilkerson, R. Aggeler, K. Yamagata, S. Remington et al., Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells, Cancer Research, vol.64, issue.3, pp.985-93, 2004.
DOI : 10.1158/0008-5472.CAN-03-1101

URL : http://cancerres.aacrjournals.org/content/canres/64/3/985.full.pdf

I. Samudio, M. Fiegl, and M. Andreeff, Mitochondrial Uncoupling and the Warburg Effect: Molecular Basis for the Reprogramming of Cancer Cell Metabolism, Cancer Research, vol.69, issue.6, pp.2163-2169, 2009.
DOI : 10.1158/0008-5472.CAN-08-3722

R. Schweppe, T. Cheung, and N. Ahn, Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses, Journal of Biological Chemistry, vol.83, issue.30, pp.20993-1003, 2006.
DOI : 10.1161/01.RES.83.3.295

A. Shukla, J. Miller, C. Cason, M. Sayan, M. Macpherson et al., Extracellular Signal-Regulated Kinase 5: A Potential Therapeutic Target for Malignant Mesotheliomas, Clinical Cancer Research, vol.19, issue.8, pp.2071-83, 2013.
DOI : 10.1158/1078-0432.CCR-12-3202

URL : http://clincancerres.aacrjournals.org/content/clincanres/19/8/2071.full.pdf

K. Smolkova, L. Plecita-hlavata, N. Bellance, G. Benard, R. Rossignol et al., Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells, The International Journal of Biochemistry & Cell Biology, vol.43, issue.7, pp.950-68, 2011.
DOI : 10.1016/j.biocel.2010.05.003

A. Starkov, The Role of Mitochondria in Reactive Oxygen Species Metabolism and Signaling, Annals of the New York Academy of Sciences, vol.281, issue.Suppl, pp.37-52, 2008.
DOI : 10.1042/bss0710097

M. Sugden, P. Caton, and M. Holness, PPAR control: it's SIRTainly as easy as PGC, Journal of Endocrinology, vol.204, issue.2, pp.93-104, 2010.
DOI : 10.1677/JOE-09-0359

URL : http://joe.endocrinology-journals.org/content/204/2/93.full.pdf

K. Sunadome, T. Yamamoto, M. Ebisuya, K. Kondoh, A. Sehara-fujisawa et al., ERK5 Regulates Muscle Cell Fusion through Klf Transcription Factors, Developmental Cell, vol.20, issue.2, pp.192-205, 2011.
DOI : 10.1016/j.devcel.2010.12.005

URL : https://doi.org/10.1016/j.devcel.2010.12.005

R. Tatake, O. Neill, M. Kennedy, C. Wayne, A. Jakes et al., Identification of pharmacological inhibitors of the MEK5/ERK5 pathway, Biochemical and Biophysical Research Communications, vol.377, issue.1, pp.120-125, 2008.
DOI : 10.1016/j.bbrc.2008.09.087

K. Verbist, R. Wang, and D. Green, T cell metabolism and the immune response, Seminars in Immunology, vol.24, issue.6, pp.399-404, 2012.
DOI : 10.1016/j.smim.2012.12.006

M. Villalba, N. Lopez-royuela, E. Krzywinska, M. Rathore, R. Hipskind et al., Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers, Anti-Cancer Agents in Medicinal Chemistry, vol.14, issue.2, pp.223-255, 2014.
DOI : 10.2174/18715206113136660374

URL : https://hal.archives-ouvertes.fr/inserm-00916461

M. Villalba, M. Rathore, N. Lopez-royuela, E. Krzywinska, J. Garaude et al., From tumor cell metabolism to tumor immune escape, The International Journal of Biochemistry & Cell Biology, vol.45, issue.1, pp.106-119, 2013.
DOI : 10.1016/j.biocel.2012.04.024

URL : https://hal.archives-ouvertes.fr/inserm-00726717

X. Wang and C. Tournier, Regulation of cellular functions by the ERK5 signalling pathway, Cellular Signalling, vol.18, issue.6, pp.753-60, 2006.
DOI : 10.1016/j.cellsig.2005.11.003

Y. Wang, Y. Liu, S. Malek, and P. Zheng, Targeting HIF1?? Eliminates Cancer Stem Cells in Hematological Malignancies, Cell Stem Cell, vol.8, issue.4, pp.399-411, 2011.
DOI : 10.1016/j.stem.2011.02.006

O. Warburg, On respiratory impairment in cancer cells, Science, vol.124, pp.269-70, 1956.

W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang et al., Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of ??-Ketoglutarate-Dependent Dioxygenases, Cancer Cell, vol.19, issue.1, pp.17-30, 2011.
DOI : 10.1016/j.ccr.2010.12.014

Q. Yang, X. Deng, B. Lu, M. Cameron, C. Fearns et al., Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein, Cancer Cell, vol.18, issue.3, pp.258-67, 2010.
DOI : 10.1016/j.ccr.2010.08.008

H. Yuan, Z. Wang, L. Li, H. Zhang, H. Modi et al., Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis, Blood, vol.28, issue.32, pp.1904-1918, 2012.
DOI : 10.1038/onc.2009.147

R. Yusuf, Y. Wang, and D. Scadden, The secrets of the bone marrow niche: Metabolic priming for AML, Nature Medicine, vol.4, issue.6, pp.865-872, 2012.
DOI : 10.1038/ncb2432

J. Zhao, Y. Kyotani, S. Itoh, H. Nakayama, M. Isosaki et al., Big Mitogen-Activated Protein Kinase 1 Protects Cultured Rat Aortic Smooth Muscle Cells From Oxidative Damage, Journal of Pharmacological Sciences, vol.116, issue.2, pp.173-80, 2011.
DOI : 10.1254/jphs.11015FP